In a new study, researchers found that type 2 diabetes can “rewire" the brain in ways similar to early Alzheimer’s disease.

Experimental drug NU-9 -- a small molecule compound approved by the U.S. Food and Drug Administration (FDA) for clinical trials for the treatment of amyotrophic lateral sclerosis (ALS) -- improves ...

Experimental drug NU-9—a small molecule compound approved by the U.S. Food and Drug Administration (FDA) for clinical trials ...

According to the authors, the research opens up new possibilities for developing the next generation of ChE inhibitors that ...

An extended study after a primary trial supports using the anti-amyloid drug lecanemab (Leqembi) for up to 36 months in ...

Neurologist Stephen Hauser, MD, of the University of California San Francisco, and epidemiology professor Alberto Ascherio, ...

According to the Alzheimer's Association, nearly 7 million Americans have Alzheimer's disease. Now, a new blood test is ...

Researchers have discovered that increased blood flow is linked to greater stiffness in the hippocampus, the brain region ...

Weight loss drugs like Ozempic gained popularity for managing obesity, diabetes, and related chronic conditions, a new study ...

Two studies suggested the diabetes/weight-loss drug may have a beneficial side effect—but more work is needed to confirm this ...

Not getting enough of the deeper stages of sleep raises the risk of brain deterioration associated with Alzheimer’s disease, ...

Sleep in midlife is a bear for many, but University of California researchers found an important link when the issue ...